Lion Biotechnologies to Present at the Jefferies 2014 Global Healthcare Conference
May 27 2014 - 8:00AM
Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company
focused on the development and commercialization of novel cancer
immunotherapies based on tumor-infiltrating lymphocytes (TILs),
today announced that Chief Executive Officer Manish Singh, Ph.D.,
will present at the Jefferies 2014 Global Healthcare Conference on
Thursday, June 5, 2014, at 12:30 p.m. Eastern in Ballroom
1. The conference is being held at The Grand Hyatt Hotel, New
York, from June 2-5, 2014.
A webcast of Dr. Singh's presentation will be available both
live and on replay. The presentation will be available via webcast
at http://wsw.com/webcast/jeff82/LBIO. A replay will also be
available for 90 days following the live presentation. The live
webcast and subsequent archived replay of Lion Biotechnologies'
presentation will also be accessible via the Investors section of
the Company's web site at http://lbio.com/investors/ under
"Recent Events."
About Lion Biotechnologies
Lion Biotechnologies, Inc. is engaged in the development of
T-cells and engineered T-cells for the treatment of various
cancers. The company's lead product candidate is a
ready-to-infuse autologous T-cell therapy utilizing
tumor-infiltrating lymphocytes (TILs) for the treatment of patients
with Stage IV metastatic melanoma, and is based on a clinical CRADA
with the National Cancer Institute along with physician-sponsored
investigational therapy at the MD Anderson Cancer Center and the H.
Lee Moffitt Cancer & Research Institute. For more information,
please visit http://www.lionbio.com.
CONTACT: Investor Relations
The Trout Group
Gitanjali Jain Ogawa
646-378-2949
gogawa@troutgroup.com